CA2047189A1 - Pharmaceutical preparation in the treatment of tonsillitis - Google Patents

Pharmaceutical preparation in the treatment of tonsillitis

Info

Publication number
CA2047189A1
CA2047189A1 CA002047189A CA2047189A CA2047189A1 CA 2047189 A1 CA2047189 A1 CA 2047189A1 CA 002047189 A CA002047189 A CA 002047189A CA 2047189 A CA2047189 A CA 2047189A CA 2047189 A1 CA2047189 A1 CA 2047189A1
Authority
CA
Canada
Prior art keywords
strains
ncib
streptococci
pharmaceutical preparation
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002047189A
Other languages
English (en)
French (fr)
Inventor
Eva Elizabeth Grahn
Stig Edvin Folke Holm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2047189A1 publication Critical patent/CA2047189A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002047189A 1989-02-15 1990-02-12 Pharmaceutical preparation in the treatment of tonsillitis Abandoned CA2047189A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8900510-2 1989-02-15
SE8900510A SE463349B (sv) 1989-02-15 1989-02-15 Farmaceutiskt preparat foer profylax mot och/eller behandling av beta-streptokockinducerad tonsillit

Publications (1)

Publication Number Publication Date
CA2047189A1 true CA2047189A1 (en) 1990-08-16

Family

ID=20375049

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002047189A Abandoned CA2047189A1 (en) 1989-02-15 1990-02-12 Pharmaceutical preparation in the treatment of tonsillitis

Country Status (28)

Country Link
US (1) US5378459A (de)
EP (1) EP0458855B1 (de)
CN (1) CN1046099A (de)
AR (1) AR247099A1 (de)
AT (1) ATE142503T1 (de)
AU (1) AU628493B2 (de)
CA (1) CA2047189A1 (de)
CS (1) CS74890A2 (de)
DD (1) DD291926A5 (de)
DE (1) DE69028520T2 (de)
DK (1) DK0458855T3 (de)
EG (1) EG19075A (de)
ES (1) ES2091818T3 (de)
FI (1) FI101452B1 (de)
GR (1) GR1000639B (de)
HU (1) HU209915B (de)
IE (1) IE900459L (de)
IL (1) IL93242A (de)
IS (1) IS1678B (de)
MY (1) MY106487A (de)
NO (1) NO178883C (de)
NZ (1) NZ232381A (de)
PH (1) PH27203A (de)
PT (1) PT93141A (de)
SE (1) SE463349B (de)
WO (1) WO1990009186A1 (de)
YU (1) YU23490A (de)
ZA (1) ZA90692B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705152A (en) * 1990-10-26 1998-01-06 Interprise Limited Antimicrobial composition
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
SE511648C2 (sv) * 1998-04-17 1999-11-01 Bacterum Ab Streptokockpreparat för behandling av öroninflammation
RU2279481C2 (ru) 1999-10-12 2006-07-10 Блис Текнолоджис Лимитед Лантибиотик
DE10139039A1 (de) * 2001-08-08 2003-05-08 Zinon Douvlis Medikamentöse Suppression maligner Proliferationsprozesse durch Aminosäuren und Aminosäurenbindungen orientierte Reaktionen
US20110256179A1 (en) 2008-11-17 2011-10-20 Essum Ab Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
CN108135200B (zh) 2015-10-01 2022-06-28 多伦多大学管理委员会 铁强化茶制品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1195613A (en) * 1981-02-17 1985-10-22 Forsyth Dental Infirmary For Children Method of treating periodontosis
US4454109A (en) * 1981-02-17 1984-06-12 Forsyth Dental Infirmary For Children Method of treating periodontosis
JPS5927833A (ja) * 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤

Also Published As

Publication number Publication date
IS3547A7 (is) 1990-08-16
DD291926A5 (de) 1991-07-18
GR900100092A (en) 1991-06-28
DE69028520T2 (de) 1997-04-03
NO913162L (no) 1991-10-07
CN1046099A (zh) 1990-10-17
GR1000639B (el) 1992-09-11
NZ232381A (en) 1992-10-28
AU5157790A (en) 1990-09-05
NO178883B (no) 1996-03-18
US5378459A (en) 1995-01-03
SE8900510D0 (sv) 1989-02-15
FI101452B (fi) 1998-06-30
EG19075A (en) 1994-06-30
NO913162D0 (no) 1991-08-13
SE463349B (sv) 1990-11-12
DK0458855T3 (da) 1996-09-30
ES2091818T3 (es) 1996-11-16
ZA90692B (en) 1990-10-31
IE900459L (en) 1990-08-15
HUT57051A (en) 1991-11-28
AR247099A1 (es) 1994-11-30
AU628493B2 (en) 1992-09-17
EP0458855B1 (de) 1996-09-11
ATE142503T1 (de) 1996-09-15
IL93242A (en) 1994-11-28
CS74890A2 (en) 1991-09-15
NO178883C (no) 1996-06-26
HU209915B (en) 1994-11-28
IS1678B (is) 1997-12-31
PH27203A (en) 1993-05-04
PT93141A (pt) 1990-08-31
EP0458855A1 (de) 1991-12-04
IL93242A0 (en) 1990-11-29
SE8900510L (sv) 1990-08-16
FI101452B1 (fi) 1998-06-30
FI913845A0 (fi) 1991-08-14
YU23490A (sh) 1993-05-28
DE69028520D1 (de) 1996-10-17
MY106487A (en) 1995-06-30
WO1990009186A1 (en) 1990-08-23

Similar Documents

Publication Publication Date Title
Roos et al. Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study
Brook et al. Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis
Emmons et al. Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case
Brook et al. Treatment of patients with a history of recurrent tonsillitis due to group A beta-hemolytic streptococci: A prospective randomized study comparing penicillin, erythromycin, and clindamycin
Rufael et al. Native valve endocarditis due to Corynebacterium striatum: case report and review
Kayser Methicillin-resistant staphylococci 1965-75
Mankiewicz et al. The role of mycobacteriophages and of cortisone in experimental tuberculosis and sarcoidosis
Gaman et al. Emergence of gentamicin-and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment
Sharquie et al. The antibacterial activity of tea in vitro and in vivo (in patients with impetigo contagiosa)
Watanakunakorn Streptococcus bovis endocarditis
CA2047189A1 (en) Pharmaceutical preparation in the treatment of tonsillitis
Brook et al. Aerobic and anaerobic bacteriology of pilonidal cyst abscess in children
LaRocco et al. Mycobacterium fortuitum peritionitis in a patient undergoing chronic peritoneal dialysis
De Almeida et al. Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil
Josefsson et al. Effect of phenoxymethylpenicillin and erythromycin prophylaxis on anaerobic bacteraemia after oral surgery
Hawkey et al. Prospective survey of fecal, urinary tract, and environmental colonization by Providencia stuartii in two geriatric wards
Pickering et al. Clinical and pharmacologic evaluation of cefazolin in children
Metcalfe et al. Effects of methotrexate on group A beta hemolytic streptococci and streptococcal infection
WO1993014770A1 (en) Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivative
Walker et al. Nalidixic acid in childhood urinary tract infection: Clinical and laboratory experience with fifty patients
Hoyme et al. Cefamandole and cefazolin in the therapy of complicated urinary tract infections
US3925160A (en) Method of producing an antibiotic
Kaufhold et al. Randomized evaluation of benzathine penicillin V twice daily versus potassium penicillin V three times daily in the treatment of group A streptococcal pharyngitis
Brook et al. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli
GINSBURG et al. Management of Group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate: versus: erythromycin estolate

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued